How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/pneumonia-caused-by-severe-acute-respiratory-syndrome-coronavirus-2.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Pneumonia caused by Severe acute respiratory syndrome coronavirus 2 — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pneumonia caused by Severe acute respiratory syndrome coronavirus 2 (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Pneumonia caused by Severe acute respiratory syndrome coronavirus 2, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Olumiant	baricitinib	Eli Lilly	Janus Kinase Inhibitor [EPC]	Tyrosine-protein kinase JAK2	2018-01-01
Roactemra	tocilizumab	Roche	Interleukin-6 Receptor Antagonist [EPC]	Interleukin-6 receptor	2010-01-01
Olumiant	Olumiant	NHS Greater Glasgow and Clyde		Casein kinase I isoform gamma-1, Citron Rho-interacting kinase, Mitogen-activated protein kinase kinase kinase 1

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Eli Lilly · 1 drug in Pneumonia caused by Severe acute respiratory syndrome coronavirus 2
NHS Greater Glasgow and Clyde · 1 drug in Pneumonia caused by Severe acute respiratory syndrome coronavirus 2
Roche · 1 drug in Pneumonia caused by Severe acute respiratory syndrome coronavirus 2

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Pneumonia caused by Severe acute respiratory syndrome coronavirus 2:

Cite this brief

Drug Landscape (2026). Pneumonia caused by Severe acute respiratory syndrome coronavirus 2 — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/pneumonia-caused-by-severe-acute-respiratory-syndrome-coronavirus-2. Accessed 2026-06-10.

Pneumonia caused by Severe acute respiratory syndrome coronavirus 2 full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing